TheraRadar
← Back
Data updated: Jun 17, 2026

OHM LABS INC

Generics
Pharmaceuticals

OHM LABS INC is a generic drug manufacturer with 10 FDA-approved products.

1985
Since
10
Drugs
-
Trials
0
New Drugs (2yr)
Modality:

OHM LABS INC's Key Drugs

OHM LABS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

OHM LABS INC's Recent FDA Approvals

New NDA/BLA approvals for OHM LABS INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

OHM LABS INC's Therapeutic Areas

Disease areas where OHM LABS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

OHM LABS INC Pipeline Snapshot

Active clinical trials for OHM LABS INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling